Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03884582 · ClinicalTrials.gov registry record

Observational Study Using the CoVa Monitoring System 3

A clinical trial, sponsored by Baxter Healthcare Corporation.

Completed
Registry status
14
Enrollment target

NCT03884582 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03884582 has completed, sponsored by Baxter Healthcare Corporation.

COMPLETED
Registry status
14 participants
Enrollment target

Study Summary

Asthma is a complex and chronic inflammatory disorder which is associated with reversible airway obstruction and bronchial hyperresponsiveness. It is one of the most prevalent chronic diseases in children and prevalence further increases worldwide. Typical symptoms of asthma are breathlessness, cough, wheezing and chest tightness. These symptoms are particularly prevalent at night-time. Understanding and tracking these symptoms can lead to better management of asthma. Auscultation using a stethoscope is standard clinical practice, however there is currently no available solution to detect respiratory sounds throughout the day and night. The aim of this study is to investigate the feasibility of detecting respiratory sounds in healthy children with the CoVa patch.

Interventions

  • DEVICE Cova Monitoring System 3

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-04-01
Est. Completion 2019-05-01

Sponsor

Baxter Healthcare Corporation

46 total trials

What the Registry Record Tells You About NCT03884582

The ClinicalTrials.gov registry entry for NCT03884582 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cova Monitoring System 3 is the first listed.

NCT03884582 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03884582 about?

NCT03884582 is a clinical study titled "Observational Study Using the CoVa Monitoring System 3". Asthma is a complex and chronic inflammatory disorder which is associated with reversible airway obstruction and bronchial hyperresponsiveness. It is one of the most prevalent chronic diseases in children and prevalence further increases worldwide. Typical symptoms of asthma are breathlessness, coug...

What is the current status of trial NCT03884582?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2019-04-01. Estimated completion is 2019-05-01.

What interventions are being tested in trial NCT03884582?

The interventions under investigation include: Cova Monitoring System 3 (DEVICE).

Who is sponsoring clinical trial NCT03884582?

This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.